PSY110 - Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes from the Rapid-Psa Study
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2016 Published by Elsevier Inc.